Anti-SLIK2/ SLITRK2/ CXorf1 monoclonal antibody

Anti-SLIK2/ SLITRK2/ CXorf1 antibody for FACS & in-vivo assay

Target products collectionGo to SLITRK2/SLITRK2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1684-Ab-1/ GM-Tg-hg-MP1684-Ab-2Anti-Human SLITRK2 monoclonal antibodyHuman
GM-Tg-rg-MP1684-Ab-1/ GM-Tg-rg-MP1684-Ab-2Anti-Rat SLITRK2 monoclonal antibodyRat
GM-Tg-mg-MP1684-Ab-1/ GM-Tg-mg-MP1684-Ab-2Anti-Mouse SLITRK2 monoclonal antibodyMouse
GM-Tg-cynog-MP1684-Ab-1/ GM-Tg-cynog-MP1684-Ab-2Anti-Cynomolgus/ Rhesus macaque SLITRK2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1684-Ab-1/ GM-Tg-felg-MP1684-Ab-2Anti-Feline SLITRK2 monoclonal antibodyFeline
GM-Tg-cang-MP1684-Ab-1/ GM-Tg-cang-MP1684-Ab-2Anti-Canine SLITRK2 monoclonal antibodyCanine
GM-Tg-bovg-MP1684-Ab-1/ GM-Tg-bovg-MP1684-Ab-2Anti-Bovine SLITRK2 monoclonal antibodyBovine
GM-Tg-equg-MP1684-Ab-1/ GM-Tg-equg-MP1684-Ab-2Anti-Equine SLITRK2 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1684-Ab-1/ GM-Tg-hg-MP1684-Ab-2; GM-Tg-rg-MP1684-Ab-1/ GM-Tg-rg-MP1684-Ab-2;
GM-Tg-mg-MP1684-Ab-1/ GM-Tg-mg-MP1684-Ab-2; GM-Tg-cynog-MP1684-Ab-1/ GM-Tg-cynog-MP1684-Ab-2;
GM-Tg-felg-MP1684-Ab-1/ GM-Tg-felg-MP1684-Ab-2; GM-Tg-cang-MP1684-Ab-1/ GM-Tg-cang-MP1684-Ab-2;
GM-Tg-bovg-MP1684-Ab-1/ GM-Tg-bovg-MP1684-Ab-2; GM-Tg-equg-MP1684-Ab-1/ GM-Tg-equg-MP1684-Ab-2
Products NameAnti-SLITRK2 monoclonal antibody
Formatmab
Target NameSLITRK2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLITRK2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SLIK2/ SLITRK2/ CXorf1 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1684
    Target NameSLITRK2
    Gene ID84631,245450,309349,699766,492190,101101200,540117,100055684
    Gene Symbol and SynonymsA930040J07,CXorf1,CXorf2,RGD1561361,SLITL1,SLITRK2,™EM257,XLID111
    Uniprot AccessionQ9H156
    Uniprot Entry NameSLIK2_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000185985
    Target ClassificationN/A

    The target: SLITRK2, gene name: SLITRK2, also named as CXorf1, CXorf2, SLITL1, ™EM257. This gene encodes an integral membrane protein that contains two N-terminal leucine-rich repeats domains and contains C-terminal regions similar to neurotrophin receptors. The encoded protein may play a role in modulating neurite activity. Alternatively spliced transcript variants encoding the same protein have been described.[provided by RefSeq, Feb 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.